|
The paper "Proteomic analyser
with applications to diagnostics and vaccines" J. Theoret. Biol. 228, 459-465 (2004) describes a
hypothetical proteomic technology that utilizes a panel of N (>>1)
reagents to characterize the skewing of V region repertoires associated with
various pathologies. The technology includes diagnostic and vaccine
aspects. The idea is that specific mixtures of the N reagents can be used
to immunize against the skewing characteristic of each of various
diseases.
|